All regulations
Nonrulemaking
FDA
Open for Comments
FDA-2024-D-1377
Cancer Clinical Trial Eligibility Criteria: Performance Status; Draft Guidance for Industry, Institutional Review Boards, Clinical Investigators; Availability
Documents
4
Comments
12
Description
OPEN
Key Dates
Comment Period OpensApr 26, 2024
Comment Period ClosesJun 26, 2024
Documents
| Type | Title | Status |
|---|---|---|
Notice |
Comment Statistics
Total Comments
12
Keywords
OC
CDER
CBER
2022-301
Guidance for Industry
Cancer Clinical Trial Eligibility Criteria
Performance Status
Institutional Review Boards
Clinical Investigators
Data from Regulations.gov